News

BioM's articles and press releases about the Bavarian biotechnology sector


The transformation of Medigene

Medi­gene fully in­teg­rates the im­mune ther­apy plat­form of Tri­anta and car­ries out a cap­it­al in­crease, bring­ing a total of EUR 29…

Chancellor Angela Merkel visits Roche in Penzberg

Ger­man chan­cel­lor An­gela Merkel and Bav­ari­an prime min­is­ter Horst See­hofer vis­ited Roche

Testinterview (EN)

Example (EN) lorem ipsum dolor sit amet, con­setetur sad­ipscing elitr, sed diam nonumy ei­r­mod tem­por in­vidunt ut labore et dolore magna…

Top Ten of European Biopharma Clusters

Bav­ari­an bi­otech is glob­ally vis­ible and lead­ing in Europe

Review analytica 2014

Great in­terest in Bav­ari­an bi­o­tech­no­logy – both at trade fair and in con­fer­ence pro­gramme

Activaero acquired by Vectura

Activaero, a private Ger­man phar­ma­ceut­ic­al com­pany fo­cused on the de­vel­op­ment of products for the treat­ment of res­pir­at­ory…

Analytica 2014 - Programme in close cooperation with Munich Biotech Cluster

Lead­ing in­ter­na­tion­al fair in ana­lyt­ics in Mu­nich (1.-4.April) with spe­cial pro­gramme "Fin­ance Day", "Per­son­al­ized Medi­cine"…

Medigene acquires Trianta Immunotherapies

Medi­gene will lever­age Tri­anta's key im­mun­o­logy know-how and in­teg­rate a team of ex­perts to be led by Prof. Do­lores J. Schendel as…

Precision Medicine Congress

BioM of­fers a 10% dis­count for the 2-day con­fer­ence in Lon­don on May 19th-20th